ATE554827T1 - Pharmazeutische zusammensetzung mit einem antitumoralen mittel und einem insbesondere aus carveol, thymol und carvacrol ausgewählten wirkstoff - Google Patents

Pharmazeutische zusammensetzung mit einem antitumoralen mittel und einem insbesondere aus carveol, thymol und carvacrol ausgewählten wirkstoff

Info

Publication number
ATE554827T1
ATE554827T1 AT06744739T AT06744739T ATE554827T1 AT E554827 T1 ATE554827 T1 AT E554827T1 AT 06744739 T AT06744739 T AT 06744739T AT 06744739 T AT06744739 T AT 06744739T AT E554827 T1 ATE554827 T1 AT E554827T1
Authority
AT
Austria
Prior art keywords
carveol
carvacrol
thymol
pharmaceutical composition
active ingredient
Prior art date
Application number
AT06744739T
Other languages
English (en)
Inventor
Adnane Remmal
Original Assignee
Advanced Scient Developements
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Scient Developements filed Critical Advanced Scient Developements
Application granted granted Critical
Publication of ATE554827T1 publication Critical patent/ATE554827T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06744739T 2005-05-13 2006-05-15 Pharmazeutische zusammensetzung mit einem antitumoralen mittel und einem insbesondere aus carveol, thymol und carvacrol ausgewählten wirkstoff ATE554827T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2005/001314 WO2006120495A1 (fr) 2005-05-13 2005-05-13 Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol
PCT/IB2006/001328 WO2006120564A1 (fr) 2005-05-13 2006-05-15 Composition pharmaceutique comprenant un antiviral , un antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol , le thymol, l' eugenol, le borneol et le carvacrol

Publications (1)

Publication Number Publication Date
ATE554827T1 true ATE554827T1 (de) 2012-05-15

Family

ID=35427309

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06744739T ATE554827T1 (de) 2005-05-13 2006-05-15 Pharmazeutische zusammensetzung mit einem antitumoralen mittel und einem insbesondere aus carveol, thymol und carvacrol ausgewählten wirkstoff

Country Status (16)

Country Link
US (2) US20080171768A1 (de)
EP (2) EP1879656B1 (de)
JP (1) JP5073651B2 (de)
CN (2) CN101193682B (de)
AP (1) AP2437A (de)
AT (1) ATE554827T1 (de)
BR (2) BRPI0610130A2 (de)
CA (2) CA2606887C (de)
DK (2) DK1879656T3 (de)
EA (1) EA015168B1 (de)
ES (2) ES2386292T3 (de)
MA (2) MA29908B1 (de)
PT (2) PT1883452E (de)
TN (2) TNSN07423A1 (de)
WO (3) WO2006120495A1 (de)
ZA (1) ZA200710785B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008029136A1 (en) * 2006-09-05 2008-03-13 Ultra Biotech Limited Pharmaceutical composition and method for cancer treatment based on combinational use of conventional or plant-derived anticancer agents and geranium oil or compounds thereof
US20080293648A1 (en) * 2007-01-05 2008-11-27 Saha Pharmaceuticals, Inc. Compositions and Methods for Cancer Treatment
BRPI1009199A2 (pt) 2009-03-17 2016-03-08 Concert Pharmaceuticals Inc compostos de pirazinoisoquinolina
MX2012003563A (es) 2009-09-24 2012-04-30 Unilever Nv Agente desinfectante que comprende eugenol, terpineol y timol.
CN103354741B (zh) 2010-12-07 2016-01-13 荷兰联合利华有限公司 口腔护理组合物
WO2013064360A2 (en) 2011-11-03 2013-05-10 Unilever N.V. A personal cleaning composition
CN102579449B (zh) * 2012-03-30 2013-08-07 厦门大学 一种可提高肿瘤对紫杉醇敏感性的联合用药
GB201404505D0 (en) 2013-09-06 2014-04-30 Mars Inc Oral anti-parasitic composition
JP6487534B2 (ja) 2014-09-05 2019-03-20 シンビオミックス セラピューティクス、エルエルシー 細菌性膣炎の治療に使用するためのセクニダゾール
EP3270907A1 (de) * 2015-03-20 2018-01-24 Sammy Oyoo OPIYO Verwendung von suramin- und arginase-inhibitoren bei maligner neoplasie
US11253501B2 (en) 2015-06-01 2022-02-22 Lupin Inc. Secnidazole formulations and use in treating bacterial vaginosis
CN105147647A (zh) * 2015-08-19 2015-12-16 华南理工大学 右旋龙脑作为抗肿瘤药物增敏剂的应用
CN109562182A (zh) 2016-06-02 2019-04-02 先进科学发展公司 包含桉树脑和阿莫西林的药物制剂
BR112019020225A2 (pt) * 2017-03-28 2020-04-22 IRP Health Pty Ltd alcaloides berberina na prevenção e/ou tratamento de doença intestinal
KR20230061465A (ko) 2020-09-04 2023-05-08 엘랑코 유에스 인코포레이티드 기호성 제형
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof
CN112972437B (zh) * 2021-02-19 2022-03-25 沈阳伟嘉生物技术有限公司 一种包含碘硝酚的长效外用制剂及其制备方法和用途
CN121550195A (zh) * 2026-01-21 2026-02-24 哈尔滨医科大学 β-紫罗兰酮在制备肿瘤免疫调节剂中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3634697A1 (de) * 1986-10-11 1988-04-21 Dentaire Ivoclar Ets Dentalwerkstoff zur bekaempfung von karies und parodontose
DE19509697A1 (de) * 1995-03-08 1996-09-12 Schering Ag Neue Borneole, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
US5916566A (en) * 1995-06-07 1999-06-29 Avmax, Inc. Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds
EP1137427A1 (de) * 1998-12-07 2001-10-04 Ecosmart Technologies Inc. Krebsbehandlung zusammensetzung und verfahren mittels natürlicher pflanzlicher äetherischer öle mit signaltransduktion modulatoren
US6536268B1 (en) * 1999-11-01 2003-03-25 Siemens Vdo Automotive Corporation Utilizing increasing width for identification voltages
DE10007771A1 (de) * 2000-02-14 2001-08-23 Kleine & Steube Entoxin Gmbh Immunmodulatorisch wirksame Zusammensetzungen, Verfahren zu ihrer Herstellung und ihre Verwendung
JP2004513153A (ja) * 2000-11-09 2004-04-30 イェルク・ペーター・シューア Ｇｒａｓ香料またはその誘導体を含む殺菌性組成物を含有する薬物
WO2002053138A2 (en) * 2001-01-02 2002-07-11 Elisabeth Shanahan-Prendergast Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
WO2002062316A1 (de) * 2001-02-08 2002-08-15 Vectron Therapeutics Ag Invasomen zur therapie von erkrankungen, ihre herstellung und verwendung
ATE478684T1 (de) * 2002-02-20 2010-09-15 Ninkov Dusan Dr Antimikrobielle therapeutische zusammensetzungen und ihre verwendung
US20030225003A1 (en) * 2002-04-18 2003-12-04 Dusan Ninkov Antimicrobial therapeutic compositions for oral and topical use
AU2003296937A1 (en) * 2002-12-10 2004-06-30 Biosynexus Incorporated Topical anti-infective formulations
US20040151771A1 (en) * 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
CN100343223C (zh) * 2005-03-07 2007-10-17 常州市智能动物药业有限公司 百里酚或香芹酚的酯类化合物、制备方法及其药物活性组合物

Also Published As

Publication number Publication date
DK1883452T3 (da) 2013-02-25
CN101193682B (zh) 2012-06-13
ZA200710785B (en) 2009-06-24
DK1879656T3 (da) 2012-07-23
JP2008540505A (ja) 2008-11-20
EP1879656B1 (de) 2012-04-25
CA2606887A1 (fr) 2006-11-16
US20080171709A1 (en) 2008-07-17
AP2007004228A0 (en) 2007-12-31
EP1879656A1 (de) 2008-01-23
EA015168B1 (ru) 2011-06-30
CA2608061A1 (fr) 2006-11-16
ES2399348T3 (es) 2013-03-27
ES2386292T3 (es) 2012-08-16
US20080171768A1 (en) 2008-07-17
AP2437A (en) 2012-08-31
CA2608061C (fr) 2014-07-15
WO2006120568A2 (fr) 2006-11-16
CN101175532B (zh) 2011-12-28
TNSN07426A1 (fr) 2009-03-17
EP1883452A2 (de) 2008-02-06
CN101193682A (zh) 2008-06-04
PT1883452E (pt) 2013-02-18
EP1883452B1 (de) 2012-12-19
BRPI0610130A2 (pt) 2012-09-25
MA29908B1 (fr) 2008-11-03
BRPI0610123A2 (pt) 2012-09-25
WO2006120564A1 (fr) 2006-11-16
WO2006120495A1 (fr) 2006-11-16
TNSN07423A1 (fr) 2009-03-17
PT1879656E (pt) 2012-07-25
CN101175532A (zh) 2008-05-07
JP5073651B2 (ja) 2012-11-14
WO2006120568A3 (fr) 2007-08-23
CA2606887C (fr) 2014-07-15
MA29573B1 (fr) 2008-06-02
EA200702486A1 (ru) 2008-06-30

Similar Documents

Publication Publication Date Title
PL3075401T3 (pl) Środek konserwujący dla kompozycji kosmetycznych, toaletowych i farmaceutycznych
ZA200710785B (en) Pharmaceutical composition containing an anti parasitic agent and an active ingredient selected from carveol, thymol, eugenol, borneol, carvacrol, alpha-ionone, or beta-ionone
IL192967A0 (en) Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
ZA200705750B (en) Compositions and methods for stabilizing active pharmaceutical ingredients
IL221770A (en) Edamantyl acetamide derivatives, the pharmaceutical composition containing them and its use in the preparation of a drug
IL191804A0 (en) Solid dispersion containing an active ingredient and tablets for oral administration containing the same
IL193678A (en) Derivatives of pyrazolyl-theophane, pharmaceuticals containing them and their use in the preparation of drugs to improve cognitive activity
IL218840A0 (en) Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
IL188150A0 (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
IL195491A (en) Pharmaceutical compositions of tmc278 and processes for their preparation
ZA200900929B (en) Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same
IL188732A0 (en) Pharmaceutical compositions containing ibuprofen and famotidine
IL177533A (en) Benzimidazole derivatives, their preparation and pharmaceutical compositions comprising them
BRPI0821115A2 (pt) Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto
CL2008000442A1 (es) Composicion farmaceutica que comprende a un quitosano, un ingrediente activo cosmetico o farmaceutico, y un solvente volatil; y su uso para tratar psoriasis, micosis entre otras enfermedades.
WO2010021607A3 (en) Pharmaceutical formulation
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
CL2007001917A1 (es) Compuestos derivados de azaindol espirociclicos; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento del dolor, condiciones de panico, depresion, mal de alzheimer, migrana, entre otras.
EP2015740A4 (de) Neue niedrigdosierte pharmazeutische zusammensetzungen mit nimesulid, zubereitung und verwendung
BRPI0814891A2 (pt) Composição farmacêutica contendo composto oticamente ativo tendo atividade agonista de receptor de trombopoietina, e intermediário do mesmo.
IL188980A0 (en) Pharmaceutical formulations/composition of guanfacine suitable for single dose form adminstration daily
ATE490967T1 (de) 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
IL192206A0 (en) Topical mecamylamine formulations for ocular administration and uses thereof
BRPI0607198A2 (pt) composição, uso da composição método de tratamento doenças, e, embalagem farmacêutica